<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <id>https://finance.naver.com/news/news_list.naver?mode=LSS3D&amp;section_id=101&amp;section_id2=258&amp;section_id3=402</id>
    <title>네이버 금융 ─ 뉴스 ─ 기업 종목분석</title>
    <updated>2021-11-25T02:26:02.765Z</updated>
    <generator>https://github.com/jpmonette/feed</generator>
    <icon>https://finance.naver.com/news/favicon.ico</icon>
    <entry>
        <title type="html"><![CDATA[[단독][fn마켓워치] SK온, 프리IPO 나선다..총 3조원 규모]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004745480&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004745480&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T02:24:03.163Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004745480&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="[단독][fn마켓워치] SK온, 프리IPO 나선다..총 3조원 규모&nbsp;">[단독][fn마켓워치] SK온, 프리IPO 나선다..총 3조원 규모&nbsp;</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[상장 두 달만에 확 뜬 '탄소배출권 ETF']]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0005005332&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0005005332&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T02:24:03.165Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0005005332&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="상장 두 달만에 확 뜬 '탄소배출권 ETF'">상장 두 달만에 확 뜬 '탄소배출권 ETF'</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[FSN, 日 컴시드와 'P2E 및 NFT 사업 파트너십 MOU' 체결]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004675117&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004675117&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T02:24:03.169Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004675117&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="FSN, 日 컴시드와 'P2E 및 NFT 사업 파트너십 MOU' 체결">FSN, 日 컴시드와 'P2E 및 NFT 사업 파트너십 MOU' 체결</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주] 씨앤투스성진, 200% 무상증자·자사주 소각 소식에 25% 급등]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0003989409&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0003989409&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T01:49:37.287Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0003989409&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="[특징주] 씨앤투스성진, 200% 무상증자·자사주 소각 소식에 25% 급등">[특징주] 씨앤투스성진, 200% 무상증자·자사주 소각 소식에 25% 급등</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA['라라랜드' 품은 CJ ENM…물적분할의 악몽]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0005005281&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0005005281&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T01:49:37.288Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0005005281&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="'라라랜드' 품은 CJ ENM…물적분할의 악몽">'라라랜드' 품은 CJ ENM…물적분할의 악몽</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[[특징주] 식지 않는 메타버스 열기...AR·VR 기술주 강세]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0003989391&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0003989391&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T01:49:37.289Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0003989391&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="[특징주] 식지 않는 메타버스 열기...AR·VR 기술주 강세">[특징주] 식지 않는 메타버스 열기...AR·VR 기술주 강세</a>]]></content>
    </entry>
    <entry>
        <title type="html"><![CDATA[툴젠 "유전자교정 플랫폼 ·유전자·세포치료제 글로벌 선도 기업 도약"]]></title>
        <id>https://finance.naver.com/news/news_read.naver?article_id=0004632722&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1</id>
        <link href="https://finance.naver.com/news/news_read.naver?article_id=0004632722&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1"/>
        <updated>2021-11-25T01:49:37.291Z</updated>
        <content type="html"><![CDATA[<a href="/news/news_read.naver?article_id=0004632722&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211125&amp;page=1" title="툴젠 &quot;유전자교정 플랫폼 ·유전자·세포치료제 글로벌 선도 기업 도약&quot;">툴젠 "유전자교정 플랫폼 ·유전자·세포치료제 글로벌 선도 기업 도약"</a>]]></content>
    </entry>
</feed>